It’s not the flashiest technologies or rapid-speed AI breakthroughs that can do it. It’s the technologies laser-focused on the unglamorous but all-consuming coordination problems that suck up medical staff’s time, stress them out, and compromise patient care. The post Innovation Fatigue is Rampant: What’s the Rx to Fix It? appeared first on MedCity News.
[Sponsored] The 2025 Benefits Sentiment Index is based on a survey of 120 benefit consultants to self-insured employers and is sponsored by Quantum Health. The post Report Finds Healthcare Navigation Is at a Crossroads appeared first on MedCity News.
Acquisition talks for Metsera that played out this year culminated in an agreement with Pfizer, which agreed to buy the obesity drug developer for $4.9 billion. Novo Nordisk, a finalist in that pursuit, is positioning itself as a deal spoiler with a new unsolicited offer that shells out much more upfront cash. The post Novo…
With federal PBM reform stalled, states like California are stepping up with laws like SB 41 to boost transparency and lower drug costs. The post California Signs PBM Law: As Federal PBM Regulation Lags, the States Step Up appeared first on MedCity News.
During Reuters’ Total Health conference in Chicago, four healthcare leaders shared the strategies they believe will help fortify the workforce for the future. The post 4 Strategies Providers Are Using to Strengthen the Healthcare Workforce appeared first on MedCity News.
[Sponsored] The AI Index in RCM highlights the findings of our survey of 125 medical billing executives who offered insights and feedback on RCM tech. The post Medical Billing Professionals Share Views on AI and Health Tech appeared first on MedCity News.
The cybersecurity process is something you need to invest effort in now. Here’s some insight on conducting a security risk analysis that is impactful for the whole life of a medical device or medical device software. The post Conducting a Medical Device Security Risk Assessment appeared first on MedCity News.
Equity has to be built into the deployment strategy from day one, not treated as a future retrofit. That means prioritizing inclusion not only in the data but in the delivery, and recognizing that inclusive deployment is the foundation for inclusive datasets. The post Bias Doesn’t End at the Dataset: It Lives in the Deployment…
[Sponsored] MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed health tech executives at HLTH 2025. The post Heard at HLTH: Healthcare Executives Share Views on AI from Clinical Decision Support to OR Efficiency and Streamlining the Payment Experience appeared first on MedCity News.
Generic drugs don’t need lengthy clinical trials to support a submission seeking FDA approval. The regulator now proposes ending this testing requirement for biosimilars, products that reference complex biologic medicines. The post FDA Proposes Dropping Clinical Trial Requirements to Bring Biosimilars to Market More Quickly appeared first on MedCity News.